Retiform Sertoli–Leydig cell tumours: clinical, morphological and immunohistochemical findings

200266 citationsJournal Article

Authors

Eoghan E. Mooney · Armed Forces Institute of Pathology

Francisco F. Nogales · Universidad de Granada

Fattaneh A. Tavassoli · Armed Forces Institute of Pathology

Abstract

Immunohistochemistry is useful in distinguishing retiform Sertoli-Leydig cell tumours from other tumours that they may resemble. Inclusion of inhibin is essential in a panel of antibodies to evaluate these tumours. The clinical behaviour of these neoplasms cannot always be predicted from their morphology or clinical stage.

Topics & Keywords

Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities Sperm and Testicular Function Sexual Differentiation and Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Histopathology

Volume 41, Issue 2, pp. 110-117

DOI: 10.1046/j.1365-2559.2002.01426.x

Field-Weighted Citation Impact: 0.69